Koprowska I, Zipfel S A
Department of Pathology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Acta Cytol. 1988 Sep-Oct;32(5):675-9.
Two monoclonal antibodies (MAbs) were tested for their reactivity with antigens of exfoliated malignant cells in respiratory secretions of lung cancer patients. MAb CE 407 was developed from tissue culture cell line SW 756, derived from human uterine cervical squamous cell carcinoma; MAb BL 99-57 was developed from cell line T-24, derived from human transitional cell bladder cancer. MAb CE 407 reacted preferentially with squamous cell carcinomas (80%) and with some (44%) of the adenocarcinomas of the lung; BL 99-57 reacted with 76% of the adenocarcinomas, but only with 27% of the squamous cell carcinomas of the lung. The reactivity of BL 99-57 was more apparent in well-differentiated adenocarcinomas (89% positive), but less in poorly differentiated adenocarcinomas (65% positive). Neither of these antibodies reacted with antigens of small cell anaplastic carcinoma. These two MAbs may be useful in differentiating histologic types of lung cancer in cases that are difficult to diagnose morphologically and/or in which tissue is not available for study.
检测了两种单克隆抗体(MAb)与肺癌患者呼吸道分泌物中脱落恶性细胞抗原的反应性。单克隆抗体CE 407由源自人子宫颈鳞状细胞癌的组织培养细胞系SW 756制备;单克隆抗体BL 99 - 57由源自人移行细胞膀胱癌的细胞系T - 24制备。单克隆抗体CE 407优先与肺鳞状细胞癌(80%)以及部分(44%)肺腺癌发生反应;BL 99 - 57与76%的肺腺癌发生反应,但仅与27%的肺鳞状细胞癌发生反应。BL 99 - 57在高分化腺癌(阳性率89%)中的反应性更明显,而在低分化腺癌(阳性率65%)中反应性较低。这两种抗体均不与小细胞间变性癌的抗原发生反应。这两种单克隆抗体可能有助于在形态学诊断困难和/或无法获取组织进行研究的情况下鉴别肺癌的组织学类型。